TW234127B - - Google Patents

Info

Publication number
TW234127B
TW234127B TW081108523A TW81108523A TW234127B TW 234127 B TW234127 B TW 234127B TW 081108523 A TW081108523 A TW 081108523A TW 81108523 A TW81108523 A TW 81108523A TW 234127 B TW234127 B TW 234127B
Authority
TW
Taiwan
Application number
TW081108523A
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of TW234127B publication Critical patent/TW234127B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW081108523A 1991-10-28 1992-10-27 TW234127B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919122859A GB9122859D0 (en) 1991-10-28 1991-10-28 Novel compounds

Publications (1)

Publication Number Publication Date
TW234127B true TW234127B (zh) 1994-11-11

Family

ID=10703654

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081108523A TW234127B (zh) 1991-10-28 1992-10-27

Country Status (10)

Country Link
EP (1) EP0612324A1 (zh)
JP (1) JPH07500600A (zh)
AU (1) AU2783492A (zh)
CA (1) CA2122147A1 (zh)
GB (1) GB9122859D0 (zh)
MX (1) MX9206191A (zh)
PT (1) PT101010A (zh)
TW (1) TW234127B (zh)
WO (1) WO1993009136A1 (zh)
ZA (1) ZA928258B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013792A (en) * 1993-08-05 2000-01-11 Syntex (U.S.A.), Inc. Matrix metalloprotease inhibitors
NZ271765A (en) * 1993-08-05 1996-11-26 Syntex Inc Bridged [1,3]indolo macrocyclic lactam compounds and pharmaceutical compositions
US5773428A (en) * 1993-08-05 1998-06-30 Syntex (U.S.A.) Inc. Matrix metalloprotease inhibitors
US5840698A (en) * 1994-10-27 1998-11-24 Affymax Technologies N.V. Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5831004A (en) 1994-10-27 1998-11-03 Affymax Technologies N.V. Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
CN101686680B (zh) 2007-03-09 2015-12-09 伊沃泰克美国股份有限公司 作为p2x7调节剂的双环杂芳基化合物及其用途
JP5650642B2 (ja) 2008-08-01 2015-01-07 バイオキシネス ファーマシューティカルズ, インコーポレイテッド メチオニンアナログおよびそれらを使用する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8726714D0 (en) * 1987-11-14 1987-12-16 Beecham Group Plc Compounds
EP0401963A1 (en) * 1989-04-13 1990-12-12 Beecham Group p.l.c. Phosphonopeptides with collagenase inhibiting activity
GB9008078D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds
GB9008065D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
EP0612324A1 (en) 1994-08-31
ZA928258B (en) 1994-04-26
MX9206191A (es) 1993-06-01
WO1993009136A1 (en) 1993-05-13
AU2783492A (en) 1993-06-07
GB9122859D0 (en) 1991-12-11
PT101010A (pt) 1994-01-31
CA2122147A1 (en) 1993-05-13
JPH07500600A (ja) 1995-01-19

Similar Documents

Publication Publication Date Title
FR2685741B1 (zh)
EP0507403A3 (zh)
DE4291263T1 (zh)
EP0520216A3 (zh)
DE4193446T1 (zh)
EP0579831A4 (zh)
TW237491B (zh)
EP0543296A3 (zh)
FR2672239B1 (zh)
EP0543016A4 (zh)
TW234127B (zh)
FR2675003B1 (zh)
FR2678339B1 (zh)
ECSM91555U (zh)
JPH04100114U (zh)
EP0500121A3 (zh)
AU8570891A (zh)
EP0518088A3 (zh)
EP0543093A3 (zh)
EP0519631A3 (zh)
EP0503251A3 (zh)
EP0502742A3 (zh)
EP0498369A3 (zh)
AU8979091A (zh)
AU8969491A (zh)